samuthara chooranam for Irritable bowel syndrome(maha vatham)

Phase II non-randomised open clinical evaluation of siddha medicine samuthara chooranam for the management of maha vatham(Irritable bowel syndrome)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/037781

Enrollment

Registered

2021-11-03

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K580- Irritable bowel syndrome with diarrhea

Interventions

Intervention1: SAMUTHARA CHOORANAM: 6 grams of samuthara chooranam is administrated twice in a day with ghee for 48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Both gender ,age limit below 60 years Altered bowel habits Abdominal pain or discomfort often exacerbated by eating Abdominal distension and increased belching Dyspepsia ,heartburn, nausea

Exclusion criteria

Exclusion criteria: Ulcerative colitis Colon cancer

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by reduction in the clinical symptoms.Timepoint: 48 days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing before and after treatment.Timepoint: 48 days	—

Countries

India

Contacts

Public ContactDr P Suganya

Government Siddha Medical College

sasirekha.siddha@gmail.com9444832728

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026